ÂÜÀòÂÒÂ×

Jim Stolzenbach

Chief Development officer at Nephraegis Therapeutics

Dr. Stolzenbach has extensive pharmaceutical industry Research & Development experience. Jim previously served as Vice President for Renal and Immunology Therapeutic Development at Abbvie. He held senior leadership roles with Monsanto and Pharmacia including Vice President for Cardiovascular and Metabolic Product Development.

Dr. Stolzenbach has led global projects for both small molecule and biologic programs ranging from proof of concept trials to large Phase 3 trials designed for regulatory approval. During the course of his career, Jim co-authored over 30 publications in refereed journals with numerous abstracts for presentation.

Dr. Stolzenbach is a practiced entrepreneur serving as President of Jim Stolzenbach Consulting, LLC.

Dr. Stolzenbach has a Bachelor’s degree in Science from the University of Connecticut, a Master’s degree from the University of Georgia and a Ph.D. from Oregon State University.


Org chart